Trial intelligence / Profile preview

Flumatinib versus nilotinib or dasatinib in newly diagnosed Ph+ CML chronic phase

ChiCTR2000036212Phase 4Recruiting

Sponsor

West China Hospital of Sichuan University

Start

Sep 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1